Cargando…

The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study

BACKGROUND: The convalescent plasma of patients who recover from coronavirus disease 2019 (COVID-19) contains high titers of neutralizing antibodies, which has potential effects on the viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and improving the prognosis of patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Chun, Chen, Hui, Xie, Jianfeng, Huang, Yingzi, Yang, Yi, Du, Bin, Qiu, Haibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243335/ https://www.ncbi.nlm.nih.gov/pubmed/35783610 http://dx.doi.org/10.3389/fmed.2022.822821

Ejemplares similares

Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study
por: Kurtz, Pedro, et al.
Publicado: (2021)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Synbiotic Therapy Prevents Nosocomial Infection in Critically Ill Adult Patients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Based on a Bayesian Framework
por: Li, Cong, et al.
Publicado: (2021)

Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)

Neuroventilatory efficiency and extubation readiness in critically ill patients
por: Liu, Ling, et al.
Publicado: (2012)

Diagnosis Accuracy of Lung Ultrasound for ARF in Critically Ill Patients: A Systematic Review and Meta-Analysis
por: Yuan, Xueyan, et al.
Publicado: (2021)

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
por: Tirnea, Livius, et al.
Publicado: (2021)

Value of American Thoracic Society Guidelines in Predicting Infection or Colonization with Multidrug-Resistant Organisms in Critically Ill Patients
por: Xie, Jianfeng, et al.
Publicado: (2014)

Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients
por: Klapholz, Marc, et al.
Publicado: (2021)

CONVALESCENT PLASMA THERAPY IN CRITICALLY ILL PATIENTS WITH LATE STAGE COVID-19
por: Kumar, Neil, et al.
Publicado: (2020)

Clinical outcomes of using plasma in COVID-19 convalescent critically ill patients
por: Astola Hidalgo, I., et al.
Publicado: (2023)

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020)

Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19
por: Zhou, Cindy Ke, et al.
Publicado: (2022)

Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
por: Huang, Li, et al.
Publicado: (2021)

Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
por: Cho, YunSuk, et al.
Publicado: (2021)

What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Evaluation of Positive End-Expiratory Pressure Strategies in Patients With Coronavirus Disease 2019–Induced Acute Respiratory Distress Syndrome
por: Pan, Chun, et al.
Publicado: (2021)

Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
por: Khamis, Faryal, et al.
Publicado: (2021)

Clinical outcomes and characteristics of critically ill patients with influenza- and COVID-19-induced ARDS: A retrospective, matched cohort study
por: Volkov, Lev, et al.
Publicado: (2023)

Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Zhang, Bin, et al.
Publicado: (2020)

Critical care after the COVID-19 outbreak in China: lessons and renaissance
por: Xie, Jianfeng, et al.
Publicado: (2021)

Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID‐19
por: Donzelli, Massimo, et al.
Publicado: (2020)

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
por: Klassen, Stephen A., et al.
Publicado: (2021)

Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center
por: Ma, Xudong, et al.
Publicado: (2016)

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
por: Shankar-Hari, Manu, et al.
Publicado: (2020)

Elucidating the pivotal role of convalescent plasma therapy in critically ill COVID-19 patients: A review
por: Richard, Seidu A., et al.
Publicado: (2020)

Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile
por: Sturek, Jeffrey M., et al.
Publicado: (2022)

Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis
por: Bansal, Vikas, et al.
Publicado: (2021)

Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study
por: Jiang, Saiping, et al.
Publicado: (2020)

Early decrease of ventilatory ratio after prone position ventilation may predict successful weaning in patients with acute respiratory distress syndrome: A retrospective cohort study
por: Wang, Zhichang, et al.
Publicado: (2022)

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study
por: Rogers, Ralph, et al.
Publicado: (2020)

Classification of Patients With Sepsis According to Immune Cell Characteristics: A Bioinformatic Analysis of Two Cohort Studies
por: Zhang, Shi, et al.
Publicado: (2020)

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma
por: Ma, Tengfei, et al.
Publicado: (2022)

Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
por: Schwartz, Stephanie P., et al.
Publicado: (2020)

Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
por: Semedi, Bambang Pujo, et al.
Publicado: (2022)

Colonization With Extensively Drug-Resistant Acinetobacter baumannii and Prognosis in Critically Ill Patients: An Observational Cohort Study
por: Zheng, Yue, et al.
Publicado: (2021)

The Prevalence, Risk Factors, and Outcomes of Sepsis in Critically Ill Patients in China: A Multicenter Prospective Cohort Study
por: Wang, Meiping, et al.
Publicado: (2020)

Lymphocyte trajectories are associated with prognosis in critically ill patients: A convenient way to monitor immune status
por: Pei, Fei, et al.
Publicado: (2022)

Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype
por: Chen, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h1b54dl35u5k1a231r0qfhptg3